... Rituxan is the most common monoclonal antibody used in the treatment of WM. It recognizes a molecule called CD20 that is present on the surface of B cells. This allows the drug to target WM cancer cells specifically. ...
Waldenstrom’s Macroglobulinemia: Treatment Options
... Rituxan is the most common monoclonal antibody used in the treatment of WM. It recognizes a molecule called CD20 that is present on the surface of B cells. This allows the drug to target WM cancer cells specifically. ...
... Previous studies have suggested that a regimen of Ozurdex, Rituxan, and cyclophosphamide may also benefit people with WM.Read more about treatments for Waldenstrom’s macroglobulinemia.You Are Not Alone With Waldenstrom’s Macroglobulinemia By joining MyLymphomaTeam, the social network and online community for those living with lymphoma, you gain a support ...
Waldenstrom’s Macroglobulinemia: An Overview
... Previous studies have suggested that a regimen of Ozurdex, Rituxan, and cyclophosphamide may also benefit people with WM.Read more about treatments for Waldenstrom’s macroglobulinemia.You Are Not Alone With Waldenstrom’s Macroglobulinemia By joining MyLymphomaTeam, the social network and online community for those living with lymphoma, you gain a support ...
... Additionally, Burkitt lymphoma is often treated with a medication called Rituxan (rituximab). Rituxan is an antibody that can specifically target and destroy B cells, which are the cells that become cancerous in Burkitt lymphoma. ...
Burkitt Lymphoma: An Overview
... Additionally, Burkitt lymphoma is often treated with a medication called Rituxan (rituximab). Rituxan is an antibody that can specifically target and destroy B cells, which are the cells that become cancerous in Burkitt lymphoma. ...
... Rituxan is an antibody drug that has been engineered to recognize antigens on the surface of B cells, thereby specifically attacking the cancer cells. Rituximab is often used in combination with individual chemotherapy drugs like bendamustine. ...
Understanding Mantle Cell Lymphoma
... Rituxan is an antibody drug that has been engineered to recognize antigens on the surface of B cells, thereby specifically attacking the cancer cells. Rituximab is often used in combination with individual chemotherapy drugs like bendamustine. ...
... EPOCH is a combination of:EtoposidePrednisone, a type of corticosteroidVincristine (formerly known as Oncovin)Cyclophosphamide (sold as Cytoxan)Doxorubicin (also known as hydroxydaunorubicin and sold as Adriamycin)Chemotherapy is usually given together with a drug called rituximab (Rituxan). ...
Mesenteric Lymphoma: Your Guide
... EPOCH is a combination of:EtoposidePrednisone, a type of corticosteroidVincristine (formerly known as Oncovin)Cyclophosphamide (sold as Cytoxan)Doxorubicin (also known as hydroxydaunorubicin and sold as Adriamycin)Chemotherapy is usually given together with a drug called rituximab (Rituxan). ...
... Many people are given a chemotherapy combination known as CHOP, which consists of:Cyclophosphamide (sold as Cytoxan)Doxorubicin (also known as hydroxydaunorubicin and sold as Adriamycin)Vincristine (formerly sold as Oncovin)PrednisoneAlthough chemotherapy may be used alone, it is more commonly used with a drug called rituximab (Rituxan). ...
Tonsil Lymphoma: What You Need To Know
... Many people are given a chemotherapy combination known as CHOP, which consists of:Cyclophosphamide (sold as Cytoxan)Doxorubicin (also known as hydroxydaunorubicin and sold as Adriamycin)Vincristine (formerly sold as Oncovin)PrednisoneAlthough chemotherapy may be used alone, it is more commonly used with a drug called rituximab (Rituxan). ...
... Combinations of chemotherapy drugs are often used for certain treatment regimens, generally with a drug called Rituxan (rituximab). ...
... In one case report involving two people with benign lymphoma in the eye, doctors administered rituximab (Rituxan). Rituximab is a drug called a monoclonal antibody. It attaches to and kills B cells, a type of lymphocyte. Many of the cells found in benign lymphomas are B cells, so rituximab may help reduce or eliminate symptoms. ...
Benign Lymphoma: Your Guide
... In one case report involving two people with benign lymphoma in the eye, doctors administered rituximab (Rituxan). Rituximab is a drug called a monoclonal antibody. It attaches to and kills B cells, a type of lymphocyte. Many of the cells found in benign lymphomas are B cells, so rituximab may help reduce or eliminate symptoms. ...
... highest number of points across all categories is 5 and indicates the worst prognosis, and a zero indicates the best prognosis.Revised International Prognostic IndexWhereas the original IPI was based on expected response to standard chemotherapy and radiation treatments, the Revised International Prognostic Index (R-IPI) takes into account rituximab (Rituxan ...
Non-Hodgkin Lymphoma Prognosis: Fear, Hope, and Understanding Survival Rates
... highest number of points across all categories is 5 and indicates the worst prognosis, and a zero indicates the best prognosis.Revised International Prognostic IndexWhereas the original IPI was based on expected response to standard chemotherapy and radiation treatments, the Revised International Prognostic Index (R-IPI) takes into account rituximab (Rituxan ...
... Rather, treatment options for IVL include therapies used for other forms of lymphomas that affect the CNS.Treatment for intravascular lymphoma typically involves chemotherapy together with an antibody prescription drug called Rituxan (rituximab). ...
Intravascular Lymphoma: Your Guide
... Rather, treatment options for IVL include therapies used for other forms of lymphomas that affect the CNS.Treatment for intravascular lymphoma typically involves chemotherapy together with an antibody prescription drug called Rituxan (rituximab). ...
Join
Your Privacy Choices
